These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis. Tüter G, Kurtiş B, Serdar M. J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136 [Abstract] [Full Text] [Related]
3. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases. Toyman U, Tüter G, Kurtiş B, Kıvrak E, Bozkurt Ş, Yücel AA, Serdar M. J Periodontal Res; 2015 Feb; 50(1):44-51. PubMed ID: 24690077 [Abstract] [Full Text] [Related]
4. Comparison of CCL28, interleukin-8, interleukin-1β and tumor necrosis factor-alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis. Ertugrul AS, Sahin H, Dikilitas A, Alpaslan N, Bozoglan A. J Periodontal Res; 2013 Feb; 48(1):44-51. PubMed ID: 22812409 [Abstract] [Full Text] [Related]
5. Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study. Kaushik R, Yeltiwar RK, Pushpanshu K. J Periodontol; 2011 Sep; 82(9):1353-9. PubMed ID: 21235331 [Abstract] [Full Text] [Related]
11. Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis. Fujita Y, Ito H, Sekino S, Numabe Y. Odontology; 2012 Jul; 100(2):215-21. PubMed ID: 21932007 [Abstract] [Full Text] [Related]
14. Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. Türkoğlu O, Emingil G, Kütükçüler N, Atilla G. J Periodontol; 2009 Jun; 80(6):969-76. PubMed ID: 19485828 [Abstract] [Full Text] [Related]
15. [Interleukin-1beta and IL-1 receptor antagonist levels in gingival crevicular fluid and their relationship to clinical indices of periodontitis]. Wu YF, Tan C, Zhang JY, Meng S, Guo YH. Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):683-6. PubMed ID: 15460419 [Abstract] [Full Text] [Related]
16. Profiling biomarkers in gingival crevicular fluid using multiplex bead immunoassay. Shimada Y, Tabeta K, Sugita N, Yoshie H. Arch Oral Biol; 2013 Jun; 58(6):724-30. PubMed ID: 23395670 [Abstract] [Full Text] [Related]
18. Soluble CD14 levels in gingival crevicular fluid of subjects with untreated adult periodontitis. Jin L, Darveau RP. J Periodontol; 2001 May; 72(5):634-40. PubMed ID: 11394399 [Abstract] [Full Text] [Related]
19. Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. Rawlinson A, Grummitt JM, Walsh TF, Ian Douglas CW. J Clin Periodontol; 2003 Jan; 30(1):42-8. PubMed ID: 12702110 [Abstract] [Full Text] [Related]
20. Effects of initial periodontal therapy on interleukin-1β level in gingival crevicular fluid and clinical periodontal parameters. Oh H, Hirano J, Takai H, Ogata Y. J Oral Sci; 2015 Jun; 57(2):67-71. PubMed ID: 26062853 [Abstract] [Full Text] [Related] Page: [Next] [New Search]